Retina

Photoreceptors – and the retina in general – are highly metabolically active. But their maxed-out mitochondria can’t give much more. And when even small metabolic imbalances arise…

The unveiling of SPECTRALIS® OCT angiography* is one of the highlights for Heidelberg Engineering in 2016. Its Managing Director Dr. Kester Nahen explains the distinctive features and new possibilities of this technology.

More than 400 participants from 49 countries accepted an invitation from the Heidelberg Engineering Academy to the 13th International SPECTRALIS Symposium (ISS) in Valencia, Spain, held on October 16 and 17, 2015. This success was certainly partly due to the attractive venue, but above all, it can be attributed to the high-level international faculty, the interesting scientific program, and the constructive discussions generated.

Here, we recognize a year’s worth of innovation. Apps, IOLs, imagers, lasers, devices and drugs – the latest and greatest are all here. But which one came out on top this year?

Placental growth factor inhibitors might show efficacy in treating dry AMD as well as wet. Might aflibercept be repurposed?

Big data EMR mining (and some basic research) identifies a 50-year old drug that appears to protect against AMD development

A new tissue culture model of the retinal pigment epithelium may allow researchers to better understand the impacts of new interventions on the adult human retina

Celebrating its 25th anniversary at the American Academy of Ophthalmology (AAO) Meeting in Las Vegas, Heidelberg Engineering will present its latest diagnostic imaging technologies and services. For a quarter of a century, the company has been committed to delivering solutions to fundamental clinical needs in ophthalmology.

Leading Ophthalmologists from Three Countries Present Real World Clinical Outcomes on Oraya Therapy for Wet AMD

Optogenetics holds the potential of reversing blindness in retinal disease – but how far has the field come, and who are the key players?